| 0 (0%) | 12-26 22:18 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.98 | 1-year : | 1.14 |
| Resists | First : | 0.83 | Second : | 0.98 |
| Pivot price | 0.73  |
|||
| Supports | First : | 0.66 | Second : | 0.56 |
| MAs | MA(5) : | 0.73 |
MA(20) : | 0.73 |
| MA(100) : | 0.54  |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 22.5 |
D(3) : | 31.7 |
| RSI | RSI(14): 49.8 |
|||
| 52-week | High : | 2.27 | Low : | 0.28 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ HBIO ] has closed above bottom band by 13.5%. Bollinger Bands are 29% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.73 - 0.74 | 0.74 - 0.74 |
| Low: | 0.69 - 0.7 | 0.7 - 0.7 |
| Close: | 0.7 - 0.7 | 0.7 - 0.71 |
Sun, 21 Dec 2025
Winners Losers: Why HBIO stock is popular among millennials - July 2025 Movers & Growth Focused Stock Reports - moha.gov.vn
Wed, 17 Dec 2025
Harvard Bioscience Appoints William A. Snider to Board of Directors - TradingView — Track All Markets
Wed, 17 Dec 2025
Life science tools firm lands $40M boost and adds veteran investor - Stock Titan
Thu, 04 Dec 2025
Further Upside For Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Could Introduce Price Risks After 27% Bounce - Sahm
Sun, 09 Nov 2025
Analysts Have Been Trimming Their Harvard Bioscience, Inc. (NASDAQ:HBIO) Price Target After Its Latest Report - Yahoo Finance
Sat, 08 Nov 2025
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2025 Earnings Call Transcript - Insider Monkey
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 45 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 10.3 (%) |
| Held by Institutions | 46.8 (%) |
| Shares Short | 477 (K) |
| Shares Short P.Month | 7,050 (K) |
| EPS | -1.22 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.31 |
| Profit Margin | -61.7 % |
| Operating Margin | 1.1 % |
| Return on Assets (ttm) | -0.9 % |
| Return on Equity (ttm) | -135.7 % |
| Qtrly Rev. Growth | -6.4 % |
| Gross Profit (p.s.) | 1.11 |
| Sales Per Share | 1.95 |
| EBITDA (p.s.) | 0.11 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 9 (M) |
| Levered Free Cash Flow | 11 (M) |
| PE Ratio | -0.59 |
| PEG Ratio | 0 |
| Price to Book value | 2.19 |
| Price to Sales | 0.35 |
| Price to Cash Flow | 3.66 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|